ArticleFrontiers in oncology2021

Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome and Risk Signature Analysis.

Yiming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.